# Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions

> **NCT02724592** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Medicine Greifswald** · enrollment: 70 (actual)

## Conditions studied

- Dental Caries

## Interventions

- **DEVICE:** self assembling peptide P11-4 (Curodont™ Repair)
- **DEVICE:** fluoride varnish (Duraphat®)

## Key facts

- **NCT ID:** NCT02724592
- **Lead sponsor:** University Medicine Greifswald
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-04
- **Final completion:** 2014-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2021-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02724592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02724592, "Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT02724592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*